Biology of Blood and Marrow Transplantation
Volume 13, Issue 10 , Pages 1135-1144 , October 2007

Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating Stem Cell Differentiation

  • Elizabeth O. Hexner

      Affiliations

    • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Gwenn-aël H. Danet-Desnoyers

      Affiliations

    • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Yi Zhang

      Affiliations

    • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Dale M. Frank

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • James L. Riley

      Affiliations

    • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Bruce L. Levine

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • David L. Porter

      Affiliations

    • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Carl H. June

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Stephen G. Emerson

      Affiliations

    • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
    • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence and reprint requests: Stephen G. Emerson, MD, PhD, Pathology and Pediatrics, 510 Maloney Building, 3400 Spruce Street, Philadelphia, PA 19104.

Received 6 April 2007 ,Accepted 22 June 2007.

References 

  1. Szabolcs P, Park KD, Reese M, et al. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol. 2003;31:708–714
  2. Wagner JE, Kernan NA, Steinbuch M, et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 1995;346:214–219
  3. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397–407
  4. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–2275
  5. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–2285
  6. Christianson SW, Greiner DL, Hesselton RA, et al. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol. 1997;158:3578–3586
  7. McCune JM, Namikawa R, Kaneshima H, et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241:1632–1639
  8. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329–1337
  9. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180–191
  10. Kollet O, Peled A, Byk T, et al. Beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood. 2000;95:3102–3105
  11. McKenzie JL, Gan OI, Doedens M, Dick JE. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood. 2005;106:1259–1261
  12. Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174:6477–6489
  13. Levine BL, Bernstein WB, Connors M, et al. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol. 1997;159:5921–5930
  14. Porter DL, Levine BL, Bunin N, et al. A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation. Blood. 2006;107:1325–1331
  15. Rapoport AP, Stadtmauer EA, Aqui N, et al. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nat Med. 2005;11:1230–1237
  16. Laport GG, Levine BL, Stadtmauer EA, et al. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood. 2003;102:2004–2013
  17. Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997;89:3919–3924
  18. Porter EH, Berry RJ. The efficient design of transplantable tumour assays. Br J Cancer. 1963;17:583–595
  19. Danet GH, Pan Y, Luongo JL, et al. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest. 2003;112:126–135
  20. Thompson CB, Lindsten T, Ledbetter JA, et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA. 1989;86:1333–1337
  21. Guba SC, Stella G, Turka LA, et al. Regulation of interleukin 3 gene induction in normal human T cells. J Clin Invest. 1989;84:1701–1706
  22. Donahue RE, Wang EA, Stone DK, et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature. 1986;321:872–875
  23. Goodman JW, Burch KT, Basford NL. Graft-vs.-host activity of thymocytes: relationship to the role of thymocytes in hemopoiesis. Blood. 1972;39:850–861
  24. Goodman JW, Shinpock SG. Influence of thymus cells on erythropoiesis of parental marrow in irradiated hybrid mice. Proc Soc Exp Biol Med. 1968;129:417–422
  25. Nathan DG, Chess L, Hillman DG, et al. Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med. 1978;147:324–339
  26. Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood. 2001;98:3192–3204
  27. Martin PJ, Hansen JA, Torok-Storb B, et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant. 1988;3:445–456
  28. Storb R, Doney KC, Thomas ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood. 1982;59:236–246
  29. Kim DW, Chung YJ, Kim TG, et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood. 2004;103:1941–1948
  30. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–1347
  31. Bonnet D, Bhatia M, Wang JC, et al. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 1999;23:203–209
  32. Adams GB, Chabner KT, Foxall RB, et al. Heterologous cells cooperate to augment stem cell migration, homing, and engraftment. Blood. 2003;101:45–51
  33. Jiang Z, Adams GB, Hanash AM, et al. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2002;8:588–596
  34. Martin PJ, Akatsuka Y, Hahne M, Sale G. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood. 1998;92:2177–2181
  35. Gandy KL, Domen J, Aguila H, Weissman IL. CD8+TCR+ and CD8+TCR− cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity. 1999;11:579–590
  36. Kaufman CL, Colson YL, Wren SM, et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood. 1994;84:2436–2446
  37. Fugier-Vivier IJ, Rezzoug F, Huang Y, et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med. 2005;201:373–383
  38. Theilgaard-Monch K, Raaschou-Jensen K, Palm H, et al. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant. 2001;28:1073–1082
  39. Monteiro JP, Benjamin A, Costa ES, et al. Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood. 2005;105:1484–1491
  40. Martin PJ, Rowley SD, Anasetti C, et al. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood. 1999;94:2192–2199
  41. Nissen-Druey C, Tichelli A, Meyer-Monard S. Human hematopoietic colonies in health and disease. Acta Haematol. 2005;113:5–96
  42. Tan W, Huang W, Zhong Q, Schwarzenberger P. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J Immunol. 2006;176:6186–6193
  43. Schwarzenberger P, Huang W, Ye P, et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol. 2000;164:4783–4789
  44. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol. 1998;161:6383–6389

PII: S1083-8791(07)00332-1

doi: 10.1016/j.bbmt.2007.06.010

Biology of Blood and Marrow Transplantation
Volume 13, Issue 10 , Pages 1135-1144 , October 2007

Article Tools

* Image Usage & Resolution